Steward W - Search Results

1

A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI), in patients with advanced solid tumours.

Scott EN, Thomas AL, Molife LR, Ahmed S, Blagden S, Fong PC, Kowal K, McCoy C, Wiesinger H, Steward W, De Bono J. Scott EN, et al. Among authors: steward w. Cancer Chemother Pharmacol. 2009 Jul;64(2):425-9. doi: 10.1007/s00280-009-0968-y. Epub 2009 Mar 12. Cancer Chemother Pharmacol. 2009. PMID: 19280191 Free article. Clinical Trial.

2

A phase II study of caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer.

Thomas AL, O'Byrne K, Furber L, Jeffery K, Steward WP. Thomas AL, et al. Among authors: steward wp. Cancer Chemother Pharmacol. 2001 Oct;48(4):266-8. doi: 10.1007/s002800100351. Cancer Chemother Pharmacol. 2001. PMID: 11710625 Clinical Trial.

3

Vascular endothelial growth factor (VEGF) inhibition by small molecules.

Ahmed SI, Thomas AL, Steward WP. Ahmed SI, et al. Among authors: steward wp. J Chemother. 2004 Nov;16 Suppl 4:59-63. doi: 10.1179/joc.2004.16.Supplement-1.59. J Chemother. 2004. PMID: 15688612 Review.

4

Phase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787/ZK 222584 administered twice daily in patients with advanced cancer.

Thomas AL, Morgan B, Horsfield MA, Higginson A, Kay A, Lee L, Masson E, Puccio-Pick M, Laurent D, Steward WP. Thomas AL, et al. J Clin Oncol. 2005 Jun 20;23(18):4162-71. doi: 10.1200/JCO.2005.09.034. Epub 2005 May 2. J Clin Oncol. 2005. PMID: 15867205 Clinical Trial.

5

Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.

Thomas AL, Morgan B, Drevs J, Unger C, Wiedenmann B, Vanhoefer U, Laurent D, Dugan M, Steward WP. Thomas AL, et al. Semin Oncol. 2003 Jun;30(3 Suppl 6):32-8. doi: 10.1016/s0093-7754(03)00123-4. Semin Oncol. 2003. PMID: 12802793 Review.

6

Chemotherapy for upper gastrointestinal tumours.

Thomas AL, O'Byrne K, Steward WP. Thomas AL, et al. Among authors: steward wp. Postgrad Med J. 2000 Jun;76(896):321-7. doi: 10.1136/pmj.76.896.321. Postgrad Med J. 2000. PMID: 10824043 Free PMC article. Review.

7

Marimastat: the clinical development of a matrix metalloproteinase inhibitor.

Steward WP, Thomas AL. Steward WP, et al. Expert Opin Investig Drugs. 2000 Dec;9(12):2913-22. doi: 10.1517/13543784.9.12.2913. Expert Opin Investig Drugs. 2000. PMID: 11093361 Review.

8

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study.

Thomas AL, Cox G, Sharma RA, Steward WP, Shields F, Jeyapalan K, Muller S, O'Byrne KJ. Thomas AL, et al. Among authors: steward wp. Eur J Cancer. 2000 Dec;36(18):2329-34. doi: 10.1016/s0959-8049(00)00341-5. Eur J Cancer. 2000. PMID: 11094306 Clinical Trial.

9

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer.

O'Byrne KJ, Thomas AL, Sharma RA, DeCatris M, Shields F, Beare S, Steward WP. O'Byrne KJ, et al. Among authors: steward wp. Br J Cancer. 2002 Jul 1;87(1):15-20. doi: 10.1038/sj.bjc.6600344. Br J Cancer. 2002. PMID: 12085249 Free PMC article. Clinical Trial.

10

Recent advances in the nonsurgical treatment of upper gastrointestinal tract tumors.

Thomas AL, Steward WP. Thomas AL, et al. Among authors: steward wp. Expert Rev Anticancer Ther. 2001 Aug;1(2):258-68. doi: 10.1586/14737140.1.2.258. Expert Rev Anticancer Ther. 2001. PMID: 12113031 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters